Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Marina Cela
SVR12 Rates Higher Than 99% After Sofosbuvir/Velpatasvir Combination in HCV Infected Patients With F0-F1 Fibrosis Stage: A Real World Experience
PLoS ONE
Multidisciplinary
Related publications
Sofosbuvir and Velpatasvir: A Complete Pan-Genotypic Treatment for HCV Patients
Turkish Journal of Gastroenterology
Gastroenterology
Sofosbuvir-Based Therapies for Patients With Hepatitis C Virus Infection: Real-World Experience in China
Canadian Journal of Gastroenterology and Hepatology
Medicine
Hepatology
Gastroenterology
Real World Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) for 8 Weeks in Patients Coinfected With HCV and HIV-1
Journal of Hepatology
Hepatology
Tolerability and Discontinuation Rates in Teriflunomide-Treated Patients. A Real-World Clinical Experience
Neurosciences
Psychiatry
Mental Health
Neurology
Secondary Occult Hepatitis C Virus Infection (HCV) in Chronic HCV Patients After Treatment With Sofosbuvir and Daclatasvir
International Journal of Current Microbiology and Applied Sciences
Sofosbuvir/Velpatasvir for Chronic Hepatitis C Infection in Patients With Transfusion-Dependent Thalassemia
American Journal of Hematology
Hematology
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Genotype 3a in Pakistani Population - A Real World Experience
Pakistan Journal of Medical Sciences
Medicine
Ledipasvir and Sofosbuvir for HCV-infection in Patients Coinfected With HBV
Antiviral Therapy
Infectious Diseases
Pharmacology
A Prospective Study of Daclatasvir and Sofosbuvir in Chronic HCV-infected Kidney Transplant Recipients
BMC Nephrology
Nephrology
